MAG1

MAG1 is a Toxoplasma gondii dense granule protein central to establishing chronic infection while dampening host innate immunity (PMID:34006649). In tachyzoites it localizes to the parasitophorous vacuolar matrix, and in bradyzoites it is a 65 kDa cyst matrix antigen that also associates structurally with the cyst wall (PMID:10027984, PMID:31040239). MAG1 is actively secreted beyond the parasitophorous vacuole into the host cytosol, where it functions as an antagonist of GRA15-driven inflammasome activation: Δmag1 parasites trigger elevated IL-1β release in macrophages, complementation restores suppression, and deletion of GRA15 abolishes the IL-1β response, placing MAG1 genetically upstream as a suppressor of this pathway (PMID:34006649). Consistent with this immunomodulatory role, Δmag1 parasites show reduced virulence, impaired dissemination, and near-absent brain cyst formation in vivo (PMID:34006649). Within the bradyzoite vacuole MAG1 resides in the cyst matrix in proximity to secreted GRA proteins and physically associates with the cyst wall complex partner BPK1 (alongside MCP4, GRA8, and GRA9) (PMID:32374791, PMID:23291621). MAG1 expression is transcriptionally controlled through direct binding of bradyzoite enolase TgENO1 to a TTTTCT motif in the MAG1 promoter, and its expression is independent of BAG1 (PMID:25760592, PMID:10027984). The precise biochemical mechanism by which secreted MAG1 antagonizes inflammasome signaling has not been characterized in the available corpus.

1. 1999 Medium

   Establishing that MAG1 is a bona fide bradyzoite cyst matrix protein whose expression does not depend on the differentiation marker BAG1 defined it as an independently regulated stage-specific antigen.

   Evidence Western blot and immunofluorescence with MAG1 antisera in BAG1-null bradyzoites

   PMID:10027984

   Open questions at the time

   • Did not address MAG1 function or secretion
   • Regulatory inputs controlling MAG1 expression not identified
2. 2002 Medium

   Whether MAG1 could elicit protective host immunity was untested; immunization showed recombinant MAG1 confers partial protection against chronic cyst challenge, marking it as an immunologically active antigen.

   Evidence GST-MAG1 immunization of mice followed by lethal cyst challenge and brain cyst counting

   PMID:11865445

   Open questions at the time

   • Mechanism of protection (antibody vs cellular) not defined
   • Does not address the native function of MAG1 during infection
3. 2013 Medium

   The physical partners of MAG1 within the cyst were unknown; co-IP of BPK1 placed MAG1 in a defined cyst wall protein complex with MCP4, GRA8, and GRA9.

   Evidence Immunoprecipitation of BPK1 from in vitro bradyzoite cultures with protein identification

   PMID:23291621

   Open questions at the time

   • Single Co-IP without reciprocal validation
   • Functional consequence of the BPK1-MAG1 association not determined
4. 2015 High

   How MAG1 stage-specific expression is controlled was unresolved; TgENO1 was shown to bind a TTTTCT motif in the MAG1 promoter, identifying a direct transcriptional regulator.

   Evidence EMSA with recombinant TgENO1 plus in vivo ChIP at the MAG1 promoter

   PMID:25760592

   Open questions at the time

   • Functional impact of TgENO1 binding on MAG1 transcript levels in vivo not quantified
   • Whether other transcription factors co-regulate MAG1 unknown
5. 2020 Medium

   The spatial context of MAG1 in the bradyzoite vacuole was refined by BioID, confirming residence in the cyst matrix in proximity to secreted GRA proteins.

   Evidence Proximity biotinylation with MAG1-BirA* fusion in bradyzoites and MS identification

   PMID:32374791

   Open questions at the time

   • Proximity does not establish direct binding to identified GRAs
   • Single-lab BioID dataset
6. 2021 High

   The functional role of MAG1 was unresolved; genetics established it as a cytosol-secreted suppressor of GRA15-driven inflammasome activation required for virulence, dissemination, and cyst formation.

   Evidence Δmag1 knockout with macrophage IL-1β ELISA, heterologous complementation, Δmag1/Δgra15 double-knockout epistasis, and in vivo virulence/cyst assays

   PMID:34006649

   Open questions at the time

   • Biochemical mechanism of inflammasome suppression not defined
   • Direct host or parasite targets of secreted MAG1 unidentified
   • Mechanism linking immune suppression to cyst establishment not resolved
7. 2025 Low

   MAG1 was detected in extracellular vesicles from infected neurons, raising the possibility of EV-mediated trafficking during cyst-stage infection.

   Evidence LC-MS/MS of EVs from infected primary murine cortical neurons, confirmed by Western blot and TEM

   PMID:40523037

   Open questions at the time

   • Single proteomic identification with no MAG1-specific functional follow-up
   • Whether EV incorporation is functionally relevant unknown

• The molecular mechanism by which secreted MAG1 antagonizes GRA15/inflammasome signaling and its direct binding partners in the host cytosol remain undefined.
• No direct host-cell target of secreted MAG1 identified
• No structural or enzymatic activity assigned to MAG1
• Mechanism of secretion beyond the PV membrane unresolved